中西医结合治疗晚期非小细胞肺癌的临床效果研究(1)
[摘要] 目的 對中西医结合治疗晚期非小细胞肺癌的临床效果进行分析和研究。方法 方便选择该院在2015年12月—2016年12月期间收治的60例晚期非小细胞肺癌患者作为研究对象，按照患者的病历单双号将其划分为对照组和观察组，每组30例。采用常规化疗的方式治疗对照组患者，在此基础上，采用中医治疗观察组患者，对两组患者的治疗效果进行分析和比较。结果 对照组和观察组的总有效率为30.0%、63.3%(χ2=23.536，P<0.05);1年生存率为63.3%、83.3%(χ2=10.847，P<0.05);2年生存率为53.3%、76.7%(χ2=15.762，P<0.05)，观察组的总有效率、1年生存率、2年生存率明显高于对照组，两组患者相比差异有统计学意义(P<0.05)。在治疗后，对照组中有5例白细胞下降、4例胃肠道反应以及4例过敏反应，不良反应发生率为43.3%，观察组中有1例白细胞下降、2例胃肠道反应，不良反应发生率为10.0%。观察组的不良反应发生率明显低于对照组，两组患者相比差异有统计学意义(P<0.05)。 结论 中西医结合治疗晚期非小细胞肺癌具有很好的治疗效果，可以有效控制病情，提高患者生存质量。
, 百拇医药
[关键词] 晚期非小细胞肺癌;吉西他滨;顺铂;康艾注射液
[中图分类号] R730 [文献标识码] A [文章编号] 1674-0742(2019)06(c)-0047-03
[Abstract] Objective To analyze and study the clinical effects of integrated traditional Chinese and Western medicine in the treatment of advanced non-small cell lung cancer. Methods 60 patients with advanced non-small cell lung cancer admitted to our hospital from December 2015 to December 2016 were convenient selected as the study subjects. The patients were divided into the control group and the observation group according to their medical records. 30 cases each. The patients in the control group were treated with conventional chemotherapy. On this basis， the patients in the observation group adopted traditional Chinese medicine， analyzed and compared the curative effect of the two groups. Results The total effective rate of the control group and the observation group was 30.0%， 63.3%(χ2=23.536， P<0.05); the 1-year survival rate was 63.3%， 83.3%(χ2=10.847， P<0.05); the 2-year survival rate was 53.3%， 76.7%(χ2=15.762， P<0.05). The total effective rate， 1-year survival rate and 2-year survival rate of the observation group were significantly higher than those of the control group. The difference between the two groups was significant (P<0.05). After treatment， there were 5 cases of leukopenia， 4 cases of gastrointestinal reactions and 4 cases of allergic reactions in the control group. The incidence of adverse reactions was 43.3%. In the observation group， there was 1 case of leukopenia and 2 cases of gastrointestinal reactions. The reaction rate was 10.0%. The incidence of adverse reactions in the observation group was significantly lower than that in the control group， and the difference was significant between the two groups (P<0.05). Conclusion The combination of traditional Chinese medicine and western medicine has a good therapeutic effect on advanced non-small cell lung cancer， which can effectively control the disease and improve the quality of life of patients., 百拇医药(姬艳菊)
, 百拇医药
[关键词] 晚期非小细胞肺癌;吉西他滨;顺铂;康艾注射液
[中图分类号] R730 [文献标识码] A [文章编号] 1674-0742(2019)06(c)-0047-03
[Abstract] Objective To analyze and study the clinical effects of integrated traditional Chinese and Western medicine in the treatment of advanced non-small cell lung cancer. Methods 60 patients with advanced non-small cell lung cancer admitted to our hospital from December 2015 to December 2016 were convenient selected as the study subjects. The patients were divided into the control group and the observation group according to their medical records. 30 cases each. The patients in the control group were treated with conventional chemotherapy. On this basis， the patients in the observation group adopted traditional Chinese medicine， analyzed and compared the curative effect of the two groups. Results The total effective rate of the control group and the observation group was 30.0%， 63.3%(χ2=23.536， P<0.05); the 1-year survival rate was 63.3%， 83.3%(χ2=10.847， P<0.05); the 2-year survival rate was 53.3%， 76.7%(χ2=15.762， P<0.05). The total effective rate， 1-year survival rate and 2-year survival rate of the observation group were significantly higher than those of the control group. The difference between the two groups was significant (P<0.05). After treatment， there were 5 cases of leukopenia， 4 cases of gastrointestinal reactions and 4 cases of allergic reactions in the control group. The incidence of adverse reactions was 43.3%. In the observation group， there was 1 case of leukopenia and 2 cases of gastrointestinal reactions. The reaction rate was 10.0%. The incidence of adverse reactions in the observation group was significantly lower than that in the control group， and the difference was significant between the two groups (P<0.05). Conclusion The combination of traditional Chinese medicine and western medicine has a good therapeutic effect on advanced non-small cell lung cancer， which can effectively control the disease and improve the quality of life of patients., 百拇医药(姬艳菊)